The Lancet changes editorial policy after hydroxychloroquine Covid study retraction

New policy comes after serious quality control questions were raised about the data relied on by a study in the medical journal

One of the world’s leading medical journals, the Lancet, has reformed its editorial policies following a shocking case of apparent research misconduct involving the study of hydroxychloroquine as a treatment for Covid-19.

In May, the Lancet published a peer-reviewed study about the controversial drug hydroxychloroquine, which concluded Covid-19 patients who received the drug were dying at higher rates and experiencing more heart-related complications than other virus patients.

Continue reading…